M De Mol

1.8k total citations
14 papers, 1.5k citations indexed

About

M De Mol is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, M De Mol has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in M De Mol's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Blood properties and coagulation (3 papers). M De Mol is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Blood properties and coagulation (3 papers). M De Mol collaborates with scholars based in Belgium, Sweden and Germany. M De Mol's co-authors include Paul Declerck, Peter Carmeliet, Désiré Collen, D Collen, J M Stassen, Désiré Collen, Joost J. van den Oord, H.R. Lijnen, S Baudner and G. Müller‐Berghaus and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

M De Mol

14 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M De Mol Belgium 11 915 747 435 299 257 14 1.5k
M Keeton United States 10 597 0.7× 495 0.7× 432 1.0× 167 0.6× 227 0.9× 13 1.3k
J M Stassen Belgium 17 440 0.5× 480 0.6× 345 0.8× 223 0.7× 182 0.7× 23 1.3k
Ralf‐Peter Czekay United States 15 747 0.8× 335 0.4× 582 1.3× 130 0.4× 318 1.2× 18 1.5k
Y P Au United States 13 546 0.6× 322 0.4× 352 0.8× 221 0.7× 199 0.8× 14 1.2k
Sybille Albrecht Germany 20 228 0.2× 611 0.8× 314 0.7× 163 0.5× 169 0.7× 35 1.4k
DD Wagner United States 16 157 0.2× 1.1k 1.4× 332 0.8× 180 0.6× 416 1.6× 23 1.9k
L L Leung United States 9 304 0.3× 686 0.9× 335 0.8× 214 0.7× 208 0.8× 11 1.1k
Michelle Drews United States 7 611 0.7× 353 0.5× 324 0.7× 106 0.4× 155 0.6× 9 948
Grainne A. McMahon United States 12 439 0.5× 234 0.3× 578 1.3× 92 0.3× 214 0.8× 13 1.0k
Yasmin Akbarali United States 17 264 0.3× 432 0.6× 1.1k 2.6× 200 0.7× 119 0.5× 17 1.8k

Countries citing papers authored by M De Mol

Since Specialization
Citations

This map shows the geographic impact of M De Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M De Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M De Mol more than expected).

Fields of papers citing papers by M De Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M De Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M De Mol. The network helps show where M De Mol may publish in the future.

Co-authorship network of co-authors of M De Mol

This figure shows the co-authorship network connecting the top 25 collaborators of M De Mol. A scholar is included among the top collaborators of M De Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M De Mol. M De Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nagai, N., M De Mol, H.R. Lijnen, Peter Carmeliet, & D Collen. (1999). Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction. Circulation. 99(18). 2440–2444. 208 indexed citations
2.
Carmeliet, Peter, Lieve Moons, J M Stassen, et al.. (1997). Vascular wound healing and neointima formation induced by perivascular electric injury in mice.. PubMed. 150(2). 761–76. 163 indexed citations
3.
Carmeliet, Peter, et al.. (1994). Arterial neointima formation after trauma in mice with inactivation of the t-PA, u-PA or PAI-1 genes. Fibrinolysis and Proteolysis. 8. 101–101. 10 indexed citations
4.
Carmeliet, Peter, J M Stassen, Luc Schoonjans, et al.. (1993). Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.. Journal of Clinical Investigation. 92(6). 2756–2760. 319 indexed citations
5.
Collen, D, M De Mol, E Demarsin, F De Cock, & J M Stassen. (1993). Isolation and conditioning of recombinant staphylokinase for use in man. Fibrinolysis and Proteolysis. 7(4). 242–247. 10 indexed citations
6.
Collen, D, Karen Silence, E Demarsin, M De Mol, & H.R. Lijnen. (1992). Isolation and characterisation of natural and recombinant staphylokinase. Fibrinolysis and Proteolysis. 6(4). 203–213. 53 indexed citations
7.
Declerck, Paul, M De Mol, Douglas E. Vaughan, & Désiré Collen. (1992). Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.. Journal of Biological Chemistry. 267(17). 11693–11696. 127 indexed citations
8.
Vaughan, Douglas E., Paul Declerck, E Van Houtte, M De Mol, & Désiré Collen. (1990). Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo.. Circulation Research. 67(5). 1281–1286. 36 indexed citations
9.
Vaughan, Douglas E., Paul Declerck, M De Mol, & D Collen. (1989). Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.. Journal of Clinical Investigation. 84(2). 586–591. 28 indexed citations
10.
Declerck, Paul, M De Mol, Marie‐Christine Alessi, et al.. (1988). Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).. Journal of Biological Chemistry. 263(30). 15454–15461. 401 indexed citations
11.
Declerck, Paul, M De Mol, Margot F. K. Verstreken, H Moreau, & Désiré Collen. (1988). 276 Isolation of a plasminogen activator inhibitor 1 (PAI-1) binding protein from human plasma. Fibrinolysis and Proteolysis. 2. 121–121. 17 indexed citations
12.
Declerck, Paul, Peter Mombaerts, Paul Holvoet, M De Mol, & D Collen. (1987). Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis. Thrombosis and Haemostasis. 58(4). 1024–1029. 88 indexed citations
13.
Hoylaerts, Marc, E. Holmer, M De Mol, & D Collen. (1983). Covalent Complexes Between Low Molecular Weight Heparin Fragments and Antithrombin III – Inhibition Kinetics and Turnover Parameters. Thrombosis and Haemostasis. 49(2). 109–115. 10 indexed citations
14.
Hoylaerts, Marc, et al.. (1982). Preparation, characterization, and turnover properties of heparin-antithrombin III complexes stabilized by covalent bonds.. Journal of Biological Chemistry. 257(7). 3401–3408. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026